Literature DB >> 3918647

New hepatitis B vaccines.

A J Zuckerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918647      PMCID: PMC1418009          DOI: 10.1136/bmj.290.6467.492

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  25 in total

1.  Hepatitis B antigen activity in protein subunits produced by sonicaation.

Authors:  K R Rao; G N Vyas
Journal:  Nat New Biol       Date:  1973-02-21

2.  Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides.

Authors:  S E Brown; C R Howard; A J Zuckerman; M W Steward
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

3.  Clinical evaluation of a recombinant hepatitis B vaccine.

Authors:  W Jilg; B Lorbeer; M Schmidt; B Wilske; G Zoulek; F Deinhardt
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

4.  Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide.

Authors:  F Audibert; M Jolivet; L Chedid; J E Alouf; P Boquet; P Rivaille; O Siffert
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

5.  Who should be immunised against hepatitis B?

Authors:  A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

6.  Perinatal transmission of hepatitis B.

Authors:  A J Zuckerman
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

7.  Expression of rabies virus glycoprotein from a recombinant vaccinia virus.

Authors:  M P Kieny; R Lathe; R Drillien; D Spehner; S Skory; D Schmitt; T Wiktor; H Koprowski; J P Lecocq
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

8.  Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.

Authors:  J L Gerin; H Alexander; J W Shih; R H Purcell; G Dapolito; R Engle; N Green; J G Sutcliffe; T M Shinnick; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Human hepatitis B vaccine from recombinant yeast.

Authors:  W J McAleer; E B Buynak; R Z Maigetter; D E Wampler; W J Miller; M R Hilleman
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

10.  Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

Authors:  B Moss; G L Smith; J L Gerin; R H Purcell
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

View more
  1 in total

1.  The development of novel hepatitis B vaccines.

Authors:  A J Zuckerman
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.